Professional Advisory Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.13M | Buy |
4,500
+1,500
| +50% | +$323K | 0.14% | 44 |
|
|
2026
Q1 | $652K | Hold |
3,000
| – | – | 0.09% | 52 |
|
|
2025
Q4 | $685K | Hold |
3,000
| – | – | 0.09% | 51 |
|
|
2025
Q3 | $695K | Hold |
3,000
| – | – | 0.09% | 52 |
|
|
2025
Q2 | $557K | Sell |
3,000
-11
| -0.4% | -$2.04K | 0.08% | 52 |
|
|
2025
Q1 | $631K | Buy |
3,011
+11
| +0.4% | +$2.14K | 0.09% | 50 |
|
|
2024
Q4 | $529K | Hold |
3,000
| – | – | 0.07% | 50 |
|
|
2024
Q3 | $592K | Hold |
3,000
| – | – | 0.08% | 51 |
|
|
2024
Q2 | $515K | Sell |
3,000
-124
| -4% | -$20.5K | 0.07% | 51 |
|
|
2024
Q1 | $569K | Buy |
3,124
+24
| +0.8% | +$4.14K | 0.08% | 49 |
|
|
2023
Q4 | $480K | Hold |
3,100
| – | – | 0.07% | 48 |
|
|
2023
Q3 | $462K | Hold |
3,100
| – | – | 0.08% | 47 |
|
|
2023
Q2 | $418K | Hold |
3,100
| – | – | 0.06% | 52 |
|
|
2023
Q1 | $494K | Hold |
3,100
| – | – | 0.08% | 52 |
|
|
2022
Q4 | $501K | Hold |
3,100
| – | – | 0.08% | 52 |
|
|
2022
Q3 | $416K | Hold |
3,100
| – | – | 0.07% | 52 |
|
|
2022
Q2 | $475K | Hold |
3,100
| – | – | 0.08% | 51 |
|
|
2022
Q1 | $503K | Hold |
3,100
| – | – | 0.07% | 52 |
|
|
2021
Q4 | $420K | Hold |
3,100
| – | – | 0.06% | 57 |
|
|
2021
Q3 | $334K | Hold |
3,100
| – | – | 0.05% | 61 |
|
|
2021
Q2 | $349K | Hold |
3,100
| – | – | 0.05% | 61 |
|
|
2021
Q1 | $335K | Buy |
3,100
+100
| +3% | +$10.7K | 0.05% | 60 |
|
|
2020
Q4 | $321K | Hold |
3,000
| – | – | 0.05% | 57 |
|
|
2020
Q3 | $263K | Hold |
3,000
| – | – | 0.05% | 58 |
|
|
2020
Q2 | $295K | Hold |
3,000
| – | – | 0.06% | 53 |
|
|
2020
Q1 | $229K | Hold |
3,000
| – | – | 0.05% | 58 |
|
|
2019
Q4 | $266K | Hold |
3,000
| – | – | 0.05% | 63 |
|
|
2019
Q3 | $227K | Hold |
3,000
| – | – | 0.04% | 64 |
|
|
2019
Q2 | $218K | Hold |
3,000
| – | – | 0.04% | 62 |
|
|
2019
Q1 | $242K | Hold |
3,000
| – | – | 0.05% | 62 |
|
|
2018
Q4 | $277K | Hold |
3,000
| – | – | 0.06% | 54 |
|
|
2018
Q3 | $284K | Hold |
3,000
| – | – | 0.06% | 59 |
|
|
2018
Q2 | $278K | Hold |
3,000
| – | – | 0.06% | 55 |
|
|
2018
Q1 | $284K | Hold |
3,000
| – | – | 0.06% | 53 |
|
|
2017
Q4 | $290K | Hold |
3,000
| – | – | 0.06% | 52 |
|
|
2017
Q3 | $267K | Hold |
3,000
| – | – | 0.06% | 52 |
|
|
2017
Q2 | $218K | Buy |
+3,000
| New | +$202K | 0.05% | 55 |
|
|
2015
Q3 | – | Sell |
-3,000
| Closed | -$202K | – | 55 |
|
|
2015
Q2 | $202K | Buy |
+3,000
| New | +$196K | 0.05% | 55 |
|
Other funds holding ABBV
Professional Advisory Services's ABBV Position: Q2 2026 in Review
Professional Advisory Services increased its AbbVie (ABBV) stake by 50% in Q2 2026, buying an estimated $323K and bringing the position to 4,500 shares worth $1.13M. The position accounts for 0.14% of the portfolio, ranked #44.
Professional Advisory Services first reported a position in ABBV in Q2 2015 and has held it in 38 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Professional Advisory Services held 4,500 shares of AbbVie worth $1.13M as of Q2 2026.
- Professional Advisory Services bought 1,500 AbbVie shares in Q2 2026, an estimated $323K.
- AbbVie made up 0.14% of Professional Advisory Services's portfolio in Q2 2026, its #44 holding.
- Professional Advisory Services first reported a position in AbbVie in Q2 2015 and has held it in 38 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Professional Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.